NanoVibronix Files 8-K on Equity Sales
Ticker: FEED · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1326706
| Field | Detail |
|---|---|
| Company | Nanovibronix, Inc. (FEED) |
| Form Type | 8-K |
| Filed Date | Jan 7, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $1.47, $0.62088 |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, 8-k, sec-filing
Related Tickers: NVBX
TL;DR
NVBX filed an 8-K for unregistered equity sales - watch for dilution!
AI Summary
NanoVibronix, Inc. filed an 8-K on January 7, 2025, reporting unregistered sales of equity securities. The filing details the company's corporate information, including its state of incorporation (Delaware), principal executive offices in Tyler, Texas, and its standard industrial classification in orthopedic, prosthetic & surgical appliances & supplies.
Why It Matters
This filing indicates potential dilution for existing shareholders due to the issuance of new equity, which could impact the stock price.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can lead to dilution and signal potential financial distress or a need for capital.
Key Numbers
- 001-36445 — Commission File Number (Identifies the company's filing with the SEC)
- 01-0801232 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- NanoVibronix, Inc. (company) — Registrant
- January 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Tyler, Texas (location) — Principal executive offices
- 3842 (sic_code) — Standard Industrial Classification
FAQ
What type of equity securities were sold in the unregistered offering?
The filing does not specify the type of equity securities sold, only that it pertains to 'Unregistered Sales of Equity Securities'.
Were these sales made to accredited investors?
The filing does not provide details on the purchasers of the unregistered equity securities.
What is the purpose of this unregistered sale of equity securities?
The filing does not explicitly state the purpose of the unregistered sale of equity securities.
Does this filing indicate a need for immediate capital by NanoVibronix, Inc.?
While the filing reports unregistered sales of equity, it does not explicitly state the company's immediate capital needs.
What is the SIC code for NanoVibronix, Inc. and what does it represent?
The SIC code is 3842, which corresponds to 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
Filing Stats: 826 words · 3 min read · ~3 pages · Grade level 12.1 · Accepted 2025-01-07 08:00:26
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share NAOV Nasdaq Capital Mark
- $1.47 — of Common Stock at an exercise price of $1.47 per share (the " Exchange "). The Compa
- $0.62088 — aware law, and has an exercise price of $0.62088 per share. The forms of Warrant, Pre-
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex4-1.htm (EX-4.1) — 141KB
- ex4-2.htm (EX-4.2) — 128KB
- ex10-1.htm (EX-10.1) — 44KB
- 0001493152-25-001116.txt ( ) — 588KB
- naov-20250107.xsd (EX-101.SCH) — 3KB
- naov-20250107_lab.xml (EX-101.LAB) — 33KB
- naov-20250107_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NanoVibronix, Inc. Date: January 7, 2025 By: /s/ Stephen Brown Name: Stephen Brown Title: Chief Financial Officer